Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Alignment Healthcare (ALHC) Current Deferred Revenue (2021 - 2023)

Historic Current Deferred Revenue for Alignment Healthcare (ALHC) over the last 3 years, with Q3 2023 value amounting to $146.3 million.

  • Alignment Healthcare's Current Deferred Revenue rose 2532.82% to $146.3 million in Q3 2023 from the same period last year, while for Sep 2023 it was $146.3 million, marking a year-over-year increase of 2532.82%. This contributed to the annual value of $308000.0 for FY2022, which is 3432.84% down from last year.
  • Per Alignment Healthcare's latest filing, its Current Deferred Revenue stood at $146.3 million for Q3 2023, which was up 2532.82% from $147.5 million recorded in Q2 2023.
  • Over the past 5 years, Alignment Healthcare's Current Deferred Revenue peaked at $147.5 million during Q2 2023, and registered a low of $308000.0 during Q4 2022.
  • In the last 3 years, Alignment Healthcare's Current Deferred Revenue had a median value of $128.9 million in 2022 and averaged $92.1 million.
  • Per our database at Business Quant, Alignment Healthcare's Current Deferred Revenue plummeted by 3432.84% in 2022 and then soared by 2532.82% in 2023.
  • Quarter analysis of 3 years shows Alignment Healthcare's Current Deferred Revenue stood at $469000.0 in 2021, then crashed by 34.33% to $308000.0 in 2022, then surged by 47413.64% to $146.3 million in 2023.
  • Its Current Deferred Revenue stands at $146.3 million for Q3 2023, versus $147.5 million for Q2 2023 and $141.1 million for Q1 2023.